NASDAQ •
Healthcare •
Biotechnology •
Quote as of 05/04/2026 16:00
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization764.8 mln
Float143 mln
Earnings Date05/19/2026
Piotroski F-Score
3
/ 9
Below average
Altman Z-Score
8.61
Exceptional
Beneish M-Score
-3.59
Highly reliable
1-Year Estimate
8.03
Exceptional upside
Relative Strength
99
/ 100
Top performer
Business Description
Founded in 2011 and based in Vancouver, Washington, Absci Corporation is a clinical-stage company focused on discovering and developing antibody-based medicines. The company is currently advancing several drug candidates targeting conditions such as inflammatory bowel disease, hair loss, and cancer. To support its research, Absci works alongside a range of partners including Memorial Sloan Kettering Cancer Center, Twist Bioscience, Oracle Corporation, and Advanced Micro Devices.
